<bill session="100" type="h" number="461" updated="2014-03-22T09:51:22-04:00">
  <state datetime="1987-01-07">REFERRED</state>
  <status>
    <introduced datetime="1987-01-07"/>
  </status>
  <introduced datetime="1987-01-07"/>
  <titles>
    <title type="short" as="introduced">Obstetric Care Information Act</title>
    <title type="official" as="introduced">A bill to amend title V of the Social Security Act to require States to provide women during and after pregnancy with access to their medical records and current information on obstetrical procedures and to amend the Federal Food, Drug, and Cosmetic Act to require the dissemination of information on the effects and risks of drugs and devices on the health of pregnant and parturient women and of prospective and developing children.</title>
  </titles>
  <sponsor id="401418"/>
  <cosponsors>
    <cosponsor id="403031" joined="1987-02-19"/>
    <cosponsor id="404422" joined="1987-02-19"/>
    <cosponsor id="405236" joined="1987-03-05"/>
    <cosponsor id="405256" joined="1987-03-05"/>
    <cosponsor id="405524" joined="1987-04-09"/>
    <cosponsor id="400211" joined="1987-02-04"/>
    <cosponsor id="400216" joined="1987-03-05"/>
    <cosponsor id="406730" joined="1987-02-03"/>
    <cosponsor id="400595" joined="1987-02-25"/>
    <cosponsor id="407282" joined="1987-02-11"/>
    <cosponsor id="407772" joined="1987-02-19"/>
    <cosponsor id="408109" joined="1987-02-11"/>
    <cosponsor id="400306" joined="1987-03-05"/>
    <cosponsor id="400333" joined="1987-03-11"/>
    <cosponsor id="400409" joined="1987-02-11"/>
  </cosponsors>
  <actions>
    <action datetime="1987-01-07" state="REFERRED">
      <text>Referred to House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="1987-01-07">
      <text>Referred to House Committee on Ways and Means.</text>
    </action>
    <action datetime="1987-01-20">
      <text>Referred to Subcommittee on Health.</text>
    </action>
    <action datetime="1987-01-26">
      <text>Referred to Subcommittee on Health and the Environment.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer protection"/>
    <term name="Drug safety and regulation"/>
    <term name="Drugs"/>
    <term name="Drugs and narcotics"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Labeling"/>
    <term name="Maternal and infant welfare"/>
    <term name="Maternal health services"/>
    <term name="Medical records"/>
    <term name="Medical supplies"/>
    <term name="Obstetrics"/>
    <term name="Patients' rights"/>
    <term name="Pregnancy"/>
    <term name="Pregnant women"/>
    <term name="Social welfare"/>
    <term name="Women's health"/>
    <term name="Women's rights"/>
  </subjects>
  <amendments/>
  <summary>1/7/1987--Introduced.
Obstetric Care Information Act - Amends title V (Maternal and Child Health Services Block Grant) of the Social Security Act to require a State plan under such title to insure that a pregnant woman: (1) has the opportunity, upon her request, to inspect, copy, and have explained any medical records relating to her condition or treatment; (2) is informed, beforehand, of the side effects, risks, contraindications, and effectiveness of the procedures, drugs, or devices, and of alternative methods of treatment; and (3) consents to treatment. Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish guidelines with respect to the explanation of the side effects, risks, contraindications, and effectiveness of drugs and devices intended for use by pregnant women. Deems misbranded any drug or device offered for sale to a woman for use during pregnancy or parturition which does not meet such guidelines.</summary>
</bill>
